dr. tempero on the halo 301 trial for pancreatic cancer
Published 7 years ago • 637 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
0:38
dr. tempero on immunotherapies for pancreatic cancer
-
1:42
dr. tempero on emerging agents in pancreatic cancer
-
0:48
dr. tempero gives an overview of new therapies for pancreatic cancer
-
0:57
dr. tempero on therapies in development for the treatment of pancreatic cancer
-
1:23
dr. tempero on importance of germline testing in pancreatic cancer
-
1:25
dr. tempero on role of molecular profiling in pancreatic cancer
-
0:48
dr. tempero on immunotherapy agents in pancreatic cancer
-
1:18
dr. tempero on the role of radiation in pancreatic cancer
-
1:18
dr. tempero discusses hereditary pancreatic cancer
-
0:53
dr. tempero discusses screening for pancreatic cancer
-
1:28
margaret tempero, md: a pancreatic cancer expert and longtime supporter
-
1:05
dr. ulahannan on the prodige trial in pancreatic cancer
-
38:24
current and future directions in metastatic pancreatic cancer
-
42:41
pancreatic cancer: navigating from diagnosis to treatment
-
0:59
dr. simeone on impact of parp inhibitors on pancreatic cancer
-
1:02
dr. hendifar on the halo-202 study in metastatic pancreatic ductal adenocarcinoma
-
0:48
dr. noel on the impact of sm-88 in pancreatic cancer
-
1:53
dr. ulahannan on the prodige 35 trial in pancreatic cancer
-
1:05
are there any types of pancreatic cancer patients who should not be referred for a clinical trial?